Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast
Condition(s):Intraductal Carcinoma and Lobular Carcinoma in SituLast Updated:August 25, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Intraductal Carcinoma and Lobular Carcinoma in SituLast Updated:August 25, 2016Completed
Condition(s):Breast CancerLast Updated:May 27, 2022Completed
Condition(s):Coping Skills Training for Persistent Post-Surgical Pain; General Health EducationLast Updated:September 28, 2023Recruiting
Condition(s):Breast CancerLast Updated:December 26, 2019Completed
Condition(s):Breast NeoplasmsLast Updated:March 31, 2017Completed
Condition(s):DCISLast Updated:September 21, 2021Recruiting
Condition(s):Prostate Cancer; Breast CancerLast Updated:April 28, 2023Recruiting
Condition(s):DCISLast Updated:March 13, 2023Suspended
Condition(s):Breast Cancer; Endometrial CancerLast Updated:October 31, 2012Completed
Condition(s):Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In SituLast Updated:October 26, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.